Core profit for 1Q25E is expected to remain weak, declining YoY and QoQ due to a continued drop in Middle Eastern patients and the impact of the Ramadan holy period.
What is covered in the Full Insight:
Earnings Preview
Valuations
Quarterly Earnings
Financial Summary
Operating Highlights
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.